FABRIS, Marina
 Distribuzione geografica
Continente #
NA - Nord America 1.323
EU - Europa 375
AS - Asia 211
SA - Sud America 1
Totale 1.910
Nazione #
US - Stati Uniti d'America 1.320
CN - Cina 121
PL - Polonia 80
UA - Ucraina 67
DE - Germania 56
IT - Italia 51
GB - Regno Unito 47
TR - Turchia 47
SG - Singapore 29
SE - Svezia 28
FI - Finlandia 20
ID - Indonesia 9
CZ - Repubblica Ceca 8
BE - Belgio 7
NL - Olanda 4
AT - Austria 3
CA - Canada 2
RU - Federazione Russa 2
VN - Vietnam 2
CO - Colombia 1
ES - Italia 1
FR - Francia 1
IN - India 1
IR - Iran 1
MX - Messico 1
MY - Malesia 1
Totale 1.910
Città #
Fairfield 176
Woodbridge 151
Chandler 119
Ashburn 111
Houston 101
Ann Arbor 94
Warsaw 80
Jacksonville 75
Seattle 73
Cambridge 56
Wilmington 53
Izmir 36
Beijing 29
Shanghai 23
New York 20
Singapore 20
Nanjing 19
Princeton 19
Boardman 16
Milan 16
Bremen 13
Washington 13
Dearborn 12
San Diego 12
Tianjin 11
Brno 8
Jakarta 8
Bologna 7
Brussels 7
Los Angeles 7
Munich 7
Changsha 6
Helsinki 6
Shenyang 6
Ferrara 5
Jiaxing 5
Nanchang 5
Norwalk 5
San Mateo 4
Auburn Hills 3
Des Moines 3
Falls Church 3
Hangzhou 3
London 3
Mountain View 3
Augusta 2
Borgo Val di Taro 2
Dong Ket 2
Gorle 2
Hebei 2
Jinan 2
Kilburn 2
Leawood 2
Monza 2
Padova 2
Redwood City 2
Vreden 2
Zhengzhou 2
Acton 1
Andover 1
Changchun 1
Chengdu 1
Chicago 1
Ferrara di Monte Baldo 1
Granarolo 1
Groningen 1
Haikou 1
Hefei 1
Indiana 1
Irkutsk 1
Kuala Lumpur 1
Kunming 1
Lacco Ameno 1
Medellín 1
Montreal 1
New Bedfont 1
Ningbo 1
Orange 1
Palm Bay 1
Philadelphia 1
Phoenix 1
Poggio Renatico 1
Prescot 1
Ravenna 1
Rueil-Malmaison 1
Southwark 1
The Bronx 1
Toronto 1
Veracruz 1
Verona 1
Totale 1.510
Nome #
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 192
Exon skipping-mediated dystrophin reading frame restoration for small mutations 138
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 137
null 131
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 124
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 122
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 115
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 112
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 110
Transcriptional behavior of DMD gene duplications in DMD/BMD males 108
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 106
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 103
null 91
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 88
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 85
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 46
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 46
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 24
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 20
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 17
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 15
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 14
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 13
Totale 1.957
Categoria #
all - tutte 9.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 26 17 58 31 50 40 48 38 58 18 10
2020/2021266 24 23 9 49 13 19 16 24 10 29 37 13
2021/2022229 5 14 26 5 7 7 17 11 8 12 35 82
2022/2023297 23 33 1 34 76 31 15 23 30 9 15 7
2023/2024220 10 23 27 6 21 53 6 23 1 3 0 47
2024/202529 19 10 0 0 0 0 0 0 0 0 0 0
Totale 1.957